Ingredient Guide
L-Glutamine: Benefits, Dosage, and What the Research Says
The conditionally essential amino acid behind gut integrity, exercise recovery, and immune support
Written by Jessica Medson
L-Glutamine is the most abundant free amino acid in human plasma, accounting for more than 20% of the circulating amino acid pool, and serves as the primary fuel for intestinal epithelial cells and lymphocytes. Although the body synthesizes it under normal conditions, it becomes conditionally essential during illness, surgery, burns, or prolonged intense exercise, when demand outpaces production. The quality and specificity of clinical evidence varies widely by application: a 2019 randomized placebo-controlled trial published in Gut found that 15 g/day of oral glutamine produced a symptom response in 79.6% of post-infectious IBS-D patients versus 5.8% on placebo, while evidence for general athletic performance enhancement is weak.
What Is L-Glutamine?
L-Glutamine (abbreviated Gln) is the most abundant free amino acid in human plasma, accounting for more than 20% of the circulating amino acid pool under normal fasting conditions, with plasma concentrations typically ranging from 550 to 750 µmol/L. It is synthesized primarily in skeletal muscle and the lungs from glutamate and ammonia, and performs an extraordinary range of functions: fueling rapidly dividing cells throughout the gut and immune system, transporting nitrogen between organs, contributing to gluconeogenesis, regulating acid-base balance in the kidneys, and serving as a precursor to glutathione - the body's principal intracellular antioxidant.1
Although the body can produce glutamine under ordinary circumstances - technically making it non-essential - nutritional physiologists classify it as conditionally essential. During major metabolic stress such as surgery, severe illness, burns, trauma, or prolonged high-intensity exercise, demand outpaces endogenous production capacity. Plasma glutamine can fall below 420 µmol/L in these states, a threshold associated with elevated morbidity and mortality in hospitalized patients.1
Glutamine is found in many everyday foods. Rich dietary sources include beef, chicken, pork, fish (cod, salmon), eggs, dairy products, white rice, corn, and cabbage. Typical daily intake from a mixed diet is estimated at 3-6 g. Supplemental L-Glutamine powder or capsules are used to reach the doses evaluated in clinical trials, which range from 5 g to more than 30 g per day depending on the health goal and population studied.
How Does L-Glutamine Work?
L-Glutamine's broad physiological influence reflects several distinct mechanisms that operate in parallel across the gut, immune system, and musculoskeletal tissue.
Primary fuel for the intestinal lining
Enterocytes - the epithelial cells lining the small intestine - rely on glutamine rather than glucose as their chief energy substrate. Glutamine supports enterocyte proliferation and, critically, maintains the expression of tight-junction proteins including claudin-1, claudin-4, occludin, and zonula occludens (ZO-1, ZO-2, ZO-3) that physically seal the gaps between intestinal cells.2 When glutamine availability falls - due to illness, major surgery, or prolonged exercise - these junctions weaken, intestinal permeability increases, and bacteria and endotoxins can more readily translocate into the bloodstream.
Primary fuel for immune cells
Lymphocytes (T and B cells) and macrophages consume glutamine at rates comparable to glucose during immune activation. Glutamine depletion impairs lymphocyte proliferation and cytokine production. In intensive care settings, low plasma glutamine is monitored as a marker of immunosuppression risk, and supplementation has been studied as a way to restore immune cell function following major physiological stress.
Nitrogen transport and acid-base regulation
Glutamine is the primary carrier of nitrogen between organs. In the kidney, glutamine hydrolysis releases ammonia that buffers metabolic acids - a function that becomes particularly important during intense anaerobic exercise and during critical illness when acid-base balance is disrupted.
Antioxidant precursor
Glutamine provides cysteine and glycine building blocks required for the synthesis of glutathione. By supporting intracellular glutathione production, glutamine helps cells manage oxidative stress, which may partly explain the anti-inflammatory effects observed in certain clinical trial populations.
L-Glutamine and Gut Health
The intestinal lining turns over completely roughly every 3-5 days and consumes more glutamine per gram of tissue than almost any other organ. This biology explains why gut barrier integrity is the most extensively studied application of supplemental L-Glutamine in clinical research - and also why the evidence is nuanced rather than uniformly supportive.
What the research shows
A 2024 systematic review and meta-analysis published in Amino Acids pooled data from 10 randomized clinical trials involving 352 adult participants and found no statistically significant overall effect of glutamine supplementation on intestinal permeability.3 However, a pre-specified subgroup analysis did reveal a significant reduction in permeability when glutamine doses exceeded 30 g/day for periods shorter than two weeks - indicating that dose and timing matter considerably and may explain the inconsistent results seen across earlier trials with lower or shorter protocols.
In an acute exercise model, a randomized trial in trained runners exercising in the heat found that oral glutamine reduced the lactulose-to-rhamnose ratio - a validated marker of intestinal leakiness - in a dose-dependent manner, with the strongest protective effect at 0.5 g/kg fat-free mass.4
The most clinically significant evidence for glutamine and the gut comes from a 2019 double-blind, randomized, placebo-controlled trial published in Gut.5 The trial specifically enrolled 106 adults with post-infectious diarrhea-predominant IBS (IBS-D) who had documented intestinal hyperpermeability - a critically important design detail. Participants received either 5 g of oral glutamine three times daily (15 g/day total) or placebo for 8 weeks. The results were striking:
- Primary endpoint: 79.6% of the glutamine group achieved a reduction of at least 50 points on the IBS Severity Scoring System, versus 5.8% on placebo - a 14-fold difference
- IBS severity scores fell from 301 to 181 in the glutamine group versus remaining essentially unchanged on placebo (p<0.0001)
- Daily bowel movements declined from 5.4 to 2.9 in the treatment group (p<0.0001)
- Intestinal permeability normalized in the treatment group, with the lactulose/mannitol ratio falling from 0.11 to 0.05 (p<0.0001), while remaining elevated on placebo
Laboratory work supports the mechanism: glutamine restores expression of claudin-1, a tight-junction protein whose levels are markedly reduced in the colonic mucosa of IBS-D patients, providing a plausible biological explanation for the observed barrier repair.6
An important caveat: The 2019 IBS-D trial recruited patients with confirmed post-infectious, permeability-driven disease - a specific subgroup. These results should not be generalized to all IBS subtypes, to general gut wellness in healthy individuals, or to IBS patients who do not have documented intestinal hyperpermeability at baseline. The 2024 meta-analysis found no significant effect across a broader, more heterogeneous mix of populations, reinforcing that patient selection and dose are critical variables.
L-Glutamine and Exercise Recovery
Plasma glutamine concentrations can fall 20-30% during prolonged or high-intensity exercise, a physiological observation that has generated decades of interest in supplementation among athletes, coaches, and sports nutrition researchers. The evidence base for athletic applications, however, is considerably more modest than popular marketing suggests.
What the research shows
A 2019 narrative review in Nutrients evaluated 55 studies on glutamine supplementation in exercise contexts.7 The review found that while some studies demonstrated improvements in certain fatigue-related markers - including enhanced rates of muscle glycogen resynthesis and reduced blood ammonia accumulation during exercise - the intervention did not consistently improve physical performance outcomes. The authors concluded that glutamine supplementation appears to have "limited effects on performance" across the overall evidence base. No consistent enhancement of aerobic capacity, muscular strength, or body composition has been demonstrated.
The more defensible application is post-exercise recovery from muscle damage. A 2015 double-blind, randomized, placebo-controlled crossover study enrolled 16 healthy adults (8 male, 8 female; mean age 22 years) who consumed either L-Glutamine (0.3 g/kg body weight per day) or a matched maltodextrin placebo for 72 hours following intense eccentric unilateral knee-extension exercise.8 The glutamine group demonstrated:
- Reduced muscle soreness at 24 hours (2.8 vs. 3.4), 48 hours (2.6 vs. 3.9), and 72 hours (1.7 vs. 2.9) on a visual analog scale
- Faster recovery of peak torque at 180°/second: 91% of baseline at 72 hours versus 86% in placebo
- Greater benefits in male participants than female participants
The proposed mechanism for these recovery effects involves accelerated muscle glycogen replenishment and attenuation of exercise-induced oxidative stress rather than direct stimulation of muscle protein synthesis - which glutamine does not robustly drive the way leucine does. Athletes prioritizing muscle gain should focus primarily on total dietary protein intake and leucine-rich sources, with glutamine as a potential recovery adjunct in high-volume eccentric training blocks.
Immune Support and Specialized Medical Uses
Because glutamine is the primary energy source for rapidly dividing immune cells, it has been the subject of intensive clinical research in settings where immune function is compromised - particularly in critically ill hospitalized patients. It is also the active ingredient in the only FDA-approved L-Glutamine prescription drug.
What the research shows in critical care
A 2020 overview published in Nutrition synthesized evidence from 17 systematic reviews encompassing 117 randomized controlled trials with approximately 10,000 critically ill patients.9 Glutamine supplementation was associated with a reduced risk of infectious complications (risk ratio 0.82) and a shorter hospital length of stay (approximately 2.9 days). However, these benefits were attenuated - and in some cases disappeared - when analyses were restricted to higher-quality studies, and no significant reduction in overall ICU mortality was observed. An earlier review in Current Opinion in Gastroenterology noted that earlier meta-analyses had suggested mortality reductions, particularly with parenteral (intravenous) glutamine at doses above 0.25 g/kg/day, but that the evidence picture became more contested as larger and more rigorous multicenter trials were conducted.10
For healthy adults: The immune evidence base is largely derived from critically ill patients in intensive care, not from healthy individuals seeking immune wellness. Extrapolating ICU-level findings to everyday immune supplementation is not supported by the trial data.
FDA-approved use: sickle cell disease
The most definitive clinical evidence for L-Glutamine as a pharmaceutical agent comes from sickle cell disease research. In 2017, the U.S. Food and Drug Administration approved pharmaceutical-grade L-Glutamine (brand name Endari) for reducing the frequency of acute complications of sickle cell disease in patients aged 5 years and older. The approval was based on a Phase 3 double-blind, placebo-controlled trial published in the New England Journal of Medicine.11 The trial enrolled 230 patients randomized to pharmaceutical-grade L-Glutamine at 0.3 g/kg body weight twice daily or placebo for 48 weeks. Key outcomes:
- Median vaso-occlusive pain crises: 3 in the glutamine group versus 4 in placebo (p=0.005)
- Median hospitalizations: 2 versus 3 (p=0.005)
- Approximately two-thirds of participants received concurrent hydroxyurea therapy
- Side effects in the treatment group included nausea, chest pain, fatigue, and musculoskeletal discomfort
The proposed mechanism relates to glutamine increasing NAD (nicotinamide adenine dinucleotide) redox potential in sickle red blood cells, reducing oxidative stress on cell membranes. This is a prescription medication requiring medical supervision and is distinct from over-the-counter dietary supplement use.
Safety, Side Effects & Interactions
L-Glutamine has a well-established short-term safety profile at commonly used supplemental doses in healthy adults. The following summarizes what the evidence shows, along with important warnings for specific populations.
General tolerability
A comprehensive 2001 safety review in the Journal of Nutrition evaluated the available published evidence and concluded that "glutamine is safe in adults and in preterm infants," while acknowledging that long-term safety data in healthy individuals across all age groups remain limited.12 A 2020 randomized crossover pilot study in 14 healthy adult males tested three dose levels acutely (0.3, 0.6, and 0.9 g/kg fat-free mass) and found that while all dose levels were generally tolerated, the highest dose produced significantly more gastrointestinal symptoms than the lowest - including nausea, discomfort, belching, and upper abdominal pain.13 Starting at a lower dose (5 g/day) and titrating upward is the practical approach to minimizing GI side effects.
Common side effects
- Nausea, bloating, or stomach discomfort (most common; dose-dependent and generally mild)
- Belching or GI cramping, particularly with large single doses taken without food
Populations who should use caution or avoid L-Glutamine without medical supervision
- Kidney disease: Glutamine metabolism generates ammonia; impaired renal clearance can lead to systemic accumulation. Do not supplement without a physician's guidance.
- Liver disease or hepatic encephalopathy: The ammonia-generating effects of glutamine catabolism can worsen neurological status in patients with impaired hepatic ammonia clearance. Supplementation is contraindicated in hepatic encephalopathy.
- Seizure disorders or neurological conditions: Glutamine is a direct precursor to glutamate, a major excitatory neurotransmitter. High-dose supplementation may theoretically lower seizure threshold in susceptible individuals.
- Cancer: Glutamine is a key fuel for rapidly proliferating cells, including tumor cells. Its role in cancer nutrition is an active and contested area of research. Consult an oncologist before use.
- Pregnancy and breastfeeding: Adequate human safety data are not available for supplemental doses beyond normal dietary intake. Consult a healthcare provider before supplementing.
Drug interactions
No well-documented pharmacokinetic interactions between supplemental L-Glutamine and common medications have been established in healthy adults. Patients receiving lactulose therapy for hepatic encephalopathy should be aware that glutamine's ammonia-generating catabolism could theoretically work against the treatment's intent. As with any supplement, inform your prescribing physician and pharmacist of all products you are taking.
Dose ceiling: Short-term clinical trials in medically supervised settings have not observed adverse effects at doses up to 30-40 g/day. For unsupervised use in healthy adults, most practitioners recommend staying at or below 20 g/day. Chronic use above this level without clinical oversight is not supported by adequate long-term safety data in healthy populations.
L-Glutamine Dosage Guide
Doses below are drawn from specific clinical trials. The appropriate dose depends heavily on the goal and individual health context. Consult a healthcare provider before starting supplementation, particularly at higher doses.
| Goal | Typical Dose | Timing | Notes |
|---|---|---|---|
| General gut support | 5-10 g/day | Divided across 2-3 meals | No large RCT in healthy populations at this dose; represents the lower range of clinically studied doses and a common starting point |
| Post-infectious IBS-D with confirmed intestinal hyperpermeability | 15 g/day (5 g x 3 doses) | Three times daily, with meals | Based on Zhou et al. 2019 (Gut); evidence is specific to patients with documented post-infectious IBS-D and elevated intestinal permeability |
| Exercise recovery (muscle soreness reduction) | 0.3 g/kg body weight/day (approx. 18-24 g for a 60-80 kg adult) | Post-exercise and before bed during the 72-hour recovery window | Based on Legault et al. 2015 (IJSNEM); modest effect on soreness; no consistent performance benefit demonstrated |
| Sickle cell disease (prescription, medical use only) | 0.3 g/kg body weight twice daily (Endari brand) | Twice daily | FDA-approved pharmaceutical-grade L-Glutamine; requires a prescription and physician supervision; not for self-supplementation |
Dose and duration interact significantly. The 2024 meta-analysis found significant effects on gut permeability only at doses above 30 g/day for short durations. Higher doses carry greater risk of GI side effects.
L-Glutamine: What the Evidence Shows at a Glance
Clinical evidence for L-Glutamine varies substantially by application, population, and dose. This table summarizes the current state of the research.
| Outcome | Population | Key Research Findings | Evidence Strength |
|---|---|---|---|
| Gut permeability (general) | Adults, mixed conditions (10 RCTs, N=352) | No significant overall effect; significant reduction only in subgroup receiving >30 g/day for <2 weeks | Tier A - effect conditional on dose |
| IBS-D symptoms and gut permeability | Post-infectious IBS-D with confirmed hyperpermeability | 79.6% vs. 5.8% symptom response rate (14-fold difference) at 15 g/day x 8 weeks; permeability normalized | Tier A - single high-quality RCT; specific population |
| Intestinal permeability during exercise in heat | Trained athletes exercising in heat | Dose-dependent reduction in lactulose/rhamnose ratio; strongest effect at 0.5 g/kg fat-free mass | Tier A - small RCT |
| Muscle soreness after eccentric exercise | Healthy adults (N=16) | Lower soreness scores at 24, 48, and 72 hours; faster torque recovery at 0.3 g/kg/day | Tier A - small crossover RCT; modest effect size |
| Exercise performance (aerobic/strength) | Athletes (review of 55 studies) | No consistent improvement in aerobic capacity, strength output, or body composition | Tier A - negative finding across literature review |
| Infectious complications in critical illness | ICU patients (~10,000 across 117 RCTs) | Infection RR 0.82; approx. 2.9 days shorter hospital stay; effect attenuated in high-quality subgroups; no mortality benefit | Tier A - contested; does not apply to healthy adults |
| Sickle cell pain crises | SCD patients age 5+ (N=230, Phase 3 RCT) | Median crises: 3 vs. 4 (placebo), p=0.005; hospitalizations: 2 vs. 3; basis of 2017 FDA approval | Tier A - Phase 3 RCT (NEJM); prescription use only |
Tier A = human RCT or meta-analysis; Tier B = human observational or lower-quality trials; Tier C = animal or cell data only.
Frequently Asked Questions
What is L-Glutamine good for?
L-Glutamine is best supported by research for supporting gut barrier integrity, reducing symptoms in post-infectious diarrhea-predominant IBS with verified intestinal hyperpermeability, reducing sickle cell pain crises (FDA-approved pharmaceutical use), and modestly reducing muscle soreness after eccentric exercise. Its role as the primary fuel for intestinal and immune cells underlies these diverse applications.
How much L-Glutamine should I take per day?
Clinical trials have used 15 g/day (in three 5 g doses) for post-infectious IBS-D, and 0.3 g/kg body weight per day for post-exercise recovery - roughly 18-21 g for a 70 kg person. Many people start at 5 g/day for general use and increase gradually. The 2024 gut-permeability meta-analysis found significant effects only at doses exceeding 30 g/day for short durations.
Is L-Glutamine safe?
A 2001 Journal of Nutrition safety review concluded glutamine is safe in adults at commonly used doses. Doses up to 30 g/day appear well tolerated in short-term medical studies. People with kidney disease, liver disease, hepatic encephalopathy, seizure disorders, or cancer should consult a physician before use. Long-term safety data in healthy adults are limited.
Does L-Glutamine help with leaky gut?
The evidence is mixed. A 2024 meta-analysis of 10 RCTs found no overall significant effect on intestinal permeability, but a significant benefit did emerge in a subgroup receiving more than 30 g/day for less than 2 weeks. The strongest clinical evidence is in post-infectious IBS-D with confirmed hyperpermeability, not in healthy people with self-described leaky gut.
Does L-Glutamine help with IBS?
For a specific IBS subtype - diarrhea-predominant IBS following an enteric infection, with documented intestinal hyperpermeability - a 2019 RCT in Gut found 15 g/day produced a 14-fold higher symptom response rate than placebo over 8 weeks. Evidence is less clear for other IBS subtypes or for patients without confirmed permeability abnormalities.
Does L-Glutamine help with muscle recovery?
A 2015 double-blind crossover RCT found 0.3 g/kg/day reduced muscle soreness scores at 24, 48, and 72 hours post-eccentric exercise and accelerated strength recovery. The effect was modest and more pronounced in males. A review of 55 studies found no consistent benefit for overall athletic performance or muscle-building beyond what protein intake provides.
When should I take L-Glutamine - before or after a workout?
Most exercise recovery trials administered glutamine post-exercise or split across meals during the 72-hour recovery window. No strong evidence supports a specific pre-workout timing advantage for recovery purposes. For gut health applications, dividing the dose across meals mirrors the protocols used in clinical IBS trials.
Does L-Glutamine build muscle?
No. L-Glutamine does not significantly stimulate muscle protein synthesis the way leucine and other branched-chain amino acids do. Studies have not demonstrated that glutamine supplementation adds lean mass beyond what adequate dietary protein already provides. Its exercise-related benefits appear to be in recovery and soreness reduction, not hypertrophy.
What are the side effects of L-Glutamine?
The most common side effects are dose-dependent GI symptoms: nausea, bloating, belching, and abdominal discomfort. A 2020 pilot study found that doses of 0.9 g/kg fat-free mass produced significantly more GI symptoms than 0.3 g/kg. Starting low (5 g/day) and increasing gradually reduces these effects. Serious adverse events at typical supplemental doses are rare in published trials.
Is the L-Glutamine in supplements the same as in prescription Endari?
Pharmaceutical-grade L-Glutamine (Endari) is produced to higher purity and consistency standards than most dietary supplements and is specifically approved for sickle cell disease. Dietary supplement glutamine may vary in purity and particle size, which can affect tolerability. For sickle cell disease, only the FDA-approved pharmaceutical formulation under medical supervision should be used.
Shop L-Glutamine
HealthFare L-Glutamine supplements
Scientific References
- 1.Wischmeyer PE Clinical applications of L-glutamine: past, present, and future. Nutrition in Clinical Practice. 2003. PubMed: 16215069Human observational
- 2.Rao RK, Samak G Role of Glutamine in Protection of Intestinal Epithelial Tight Junctions. Journal of Epithelial Biology and Pharmacology. 2012. PubMed: 25810794Preclinical (animal / cell)
- 3.Abbasi F, Milajerdi A A systematic review and meta-analysis of clinical trials on the effects of glutamine supplementation on gut permeability in adults. Amino Acids. 2024. PubMed: 39397201Clinical (RCT / meta-analysis)
- 4.Pugh JN, Close GL Glutamine supplementation reduces markers of intestinal permeability during running in the heat in a dose-dependent manner. European Journal of Applied Physiology. 2017. PubMed: 29058112Clinical (RCT / meta-analysis)
- 5.Zhou QQ, Verne ML, Fields JZ, Lefante JJ, Basra S, Salameh H, Verne GN Randomised placebo-controlled trial of dietary glutamine supplements for postinfectious irritable bowel syndrome. Gut. 2019. PubMed: 30108163Clinical (RCT / meta-analysis)
- 6.Bertrand J, Ghouzali I, Guerin C, Bole-Feysot C, Gouteux M, Dechelotte P, Ducrotte P, Coeffier M Glutamine Restores Tight Junction Protein Claudin-1 Expression in Colonic Mucosa of Patients With Diarrhea-Predominant Irritable Bowel Syndrome. JPEN Journal of Parenteral and Enteral Nutrition. 2016. PubMed: 25972430Preclinical (animal / cell)
- 7.Coqueiro AY, Rogero MM, Tirapegui J Glutamine as an Anti-Fatigue Amino Acid in Sports Nutrition. Nutrients. 2019. PubMed: 30999561Human observational
- 8.Legault Z, Bagnall N, Kimmerly DS The Influence of Oral L-Glutamine Supplementation on Muscle Strength Recovery and Soreness Following Unilateral Knee Extension Eccentric Exercise. International Journal of Sport Nutrition and Exercise Metabolism. 2015. PubMed: 25811544Clinical (RCT / meta-analysis)
- 9.Apostolopoulou A, Chourdakis M Effects of glutamine supplementation on critically ill patients: Focus on efficacy and safety. An overview of systematic reviews. Nutrition. 2020. PubMed: 32877810Clinical (RCT / meta-analysis)
- 10.Wischmeyer PE Glutamine: role in critical illness and ongoing clinical trials. Current Opinion in Gastroenterology. 2008. PubMed: 18301270Human observational
- 11.Niihara Y, Miller ST, Kanter J, Lanzkron S, Smith WR, Hsu LL, Gordeuk VR, Viswanathan K, Sarnaik S, Osunkwo I, Guillaume E, Sadanandan S, Sieger L, Lasky JL, Panosyan EH, Blake OA, New TN, Bellevue R, Tran LT, Razon RL, Stark CW, Neumayr LD, Vichinsky EP A Phase 3 Trial of l-Glutamine in Sickle Cell Disease. New England Journal of Medicine. 2018. PubMed: 30021096Clinical (RCT / meta-analysis)
- 12.Garlick PJ Assessment of the safety of glutamine and other amino acids. Journal of Nutrition. 2001. PubMed: 11533313Human observational
- 13.Ogden HB, Child RB, Fallowfield JL, Delves SK, Westwood CS, Millyard A, Layden JD Gastrointestinal Tolerance of Low, Medium and High Dose Acute Oral l-Glutamine Supplementation in Healthy Adults: A Pilot Study. Nutrients. 2020. PubMed: 32992440Clinical (RCT / meta-analysis)